Our social:

February 2021

Get Your Iowa Medical Marijuana Card Online After Your Consultation with Dr. Mary Clifton M.D.

Residents of Iowa that are searching for a medical marijuana card or medical cannabis card rely on Dr. Mary Clifton M.D. Dr. Clifton is an Internal Medicine doctor with 20 years of experience in both the hospital and private practice. She is a recognized expert in CBD, Cannabis, and Medical Marijuana fields and can help you get your Iowa medical marijuana card or medical cannabis card. Fill out the form online providing your contact information, name, location and other pertinent details to get scheduled for your Iowa medical marijuana card consultation with Dr. Mary Clifton M.D. In the State of Iowa, medical marijuana cards or medical cannabis cards are available to individuals with chronic conditions, ailments or illnesses. Iowa residents that have been diagnosed with a severe, debilitating condition may be eligible for Medical Marijuana. Some qualifying conditions are: Cancer, HIV infection, AIDS, Amyotrophic Lateral Sclerosis (ALS), Parkinson’s Disease, Multiple Sclerosis (MS), Spinal Cord Injury with Spasticity, Epilepsy, Inflammatory Bowel Disease (IBD), Neuropathy, and Huntington Disease or other Chronic Pain Condition. Some complicating conditions are weight loss, severe or chronic pain, severe nausea, seizures, or severe or persistent muscle spasms. After your consultation with Dr. Mary Clifton, if you are   Read more…

Meet Dr. Mary Clifton M.D. Your Trusted Source For Medical Marijuana Cards in Iowa

Individuals in the state of Iowa that are looking to see if they qualify for a medical marijuana card can get in touch with Dr. Mary Clifton M.D. Dr. Mary Clifton is an Internal Medicine doctor with 20 years of experience in both the hospital and private practice. She can provide patient consultations in all fifty states and is licensed to prescribe in twenty states. She is a recognized expert in CBD, Cannabis, and Medical Marijuana. She is a published researcher, previously a national speaker on women’s health and osteoporosis, and author of four books, and a best-selling ebook on CBD – what you need to know, how to use cannabinoids and a COOKBOOK to support ease of use. She is also a leading voice in telemedicine to bridge the gap in healthcare availability and affordable lab testing for long-term wellness. Dr. Clifton has a special interest in innovation in health care delivery and patient empowerment. A previous alumni board member for 8 years at Michigan State University’s medical school, she completed her residency training with MSU in Grand Rapids, MI. Iowa residents that have been diagnosed with a severe, debilitating condition may be eligible for an Iowa medical marijuana   Read more…

Dr. Mary Clifton M.D. of Iowa Engages Findit To Help Improve Overall Web Presence in Search and Social

Findit, Inc., a Nevada Corporation (OTC PINK:FDIT) owner of Findit.com, a full-service social networking management platform and online marketing service, has been retained by Dr. Mary Clifton M.D. of Iowa to improve overall web presence and exposure throughout social media. Dr. Mary Clifton of Iowa has engaged Findit to help improve overall online exposure throughout search and social media with a customized marketing campaign. Findit will produce fresh content on a daily basis highlighting Dr. Mary Clifton M.D. as the trusted source for medical marijuana cards and medical cannabis cards in Iowa. Iowa residents that have been diagnosed with a severe, debilitating condition may be eligible for Medical Marijuana. Some qualifying conditions are: Cancer, HIV infection, AIDS, Amyotrophic Lateral Sclerosis (ALS), Parkinson’s Disease, Multiple Sclerosis (MS), Spinal Cord Injury with Spasticity, Epilepsy, Inflammatory Bowel Disease (IBD), Neuropathy, and Huntington Disease or other Chronic Pain Condition. Some complicating conditions are weight loss, severe or chronic pain, severe nausea, seizures, or severe or persistent muscle spasms. After your consultation with Dr. Mary Clifton, if you are eligible, you will receive your certifying documentation immediately and be registered by Dr. Clifton for a Medical Marijuana Card. As part of her campaign, Findit will   Read more…

First Ever FDA Authorized Over-the-Counter At-Home Rapid Test Kit For Coronavirus Backed by Biden Administration, as Global WholeHealth Partners Corp. Pioneers The Only Biodegradable Plant Based Plastic for Medical Devices

Global WholeHealth Partners Corp, (OTC:GWHP) a multinational medical diagnostics supplier of over 70+ products with 56 already FDA approved and several approved for export only including Dengue, Ebola, Zika, Malaria and also offering one of the largest lines of tests for CoViD19 SARS2, announces that they are pioneers of the only biodegradable plant based plastic for medical devices after receiving provisional patent. As the Biden administration announced on Monday a big push to make rapid COVID-19 home tests available with a $230 million federal contract through the Department of Defense, Global WholeHealth Partners Corp. (OTC:GWHP) CEO, Charles Strongo, said, “We understand the growth needed in the in-vitro diagnostic segment and the need for more rapid tests, and at the same time we understand that there is also a need to GO GREEN.” “We took that challenge and created a proper mix of plant based material which is 100% biodegradable, to make a plastic that is biodegradable to help the medical industry,” said Mr. Strongo.   Global WholeHealth Partners acknowledges the fact that tens of millions of plastic medical devices are used every month in the US alone and hundreds of millions throughout the world. Just in the US alone, Healthcare   Read more…

AIkido Pharma Appoints Dr. Scott T. Tagawa, M.D. to Scientific Advisory Board

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Dr. Scott T. Tagawa, M.D., M.S., FACP, a Professor of Medicine and Urology at Weill Cornell Medicine and an Attending Physician at New York-Presbyterian-Weill Cornell Medical Center, has joined the Company’s Scientific Advisory Board. (PRNewsfoto/AIkido Pharma Incorporated) “Scott is a leading scholar in the field of oncology medicine and research,” commented Mr. Anthony Hayes, CEO of AIkido. “His experience and expertise will be of tremendous value as we further our efforts to develop therapeutic treatments for cancer and leverage the technologies we have licensed. Dr. Tagawa is also the principle investigator for the targeted radiopharmaceutical therapy at Weil Cornell and his addition to our advisory board demonstrates our support for this innovative technology.” Dr. Scott T. Tagawa, MD, MS, FACP is a Professor of Medicine & Urology at Weill Cornell Medicine, and an Attending Physician at NewYork-Presbyterian – Weill Cornell Medical Center. Dr. Tagawa earned his BS from Georgetown University. He received his MD at the University of Southern California School of Medicine and after completing his internship and residency training there, he became Chief Resident. Subsequently, he underwent fellowship training in Hematology and Medical Oncology, being appointed Chief Fellow for his final two   Read more…

Iconic Hip-Hop Photographer Ricky Powell Passes Away At 59

It’s another sad day for the Hip Hop industry – iconic Hip-Hop Photographer Ricky Powell has passed away at the age of 59. So far, the cause of death has not yet been revealed by Powell’s team, but in regard to his passing, Powell’s manager and business partner did release a statement to Complex stating, “I just want to let everybody know he was a very special man, and he will be sorely missed.” Throughout his lengthy career, Powell built a decorated CV for himself by working with house-hold names including celebrities and hip-hop stars alike such as:  LL Cool J, Run DMC, Madonna, Andy Warhol, Jean-Michel Basquiat, Public Enemy, and, most famously, the Beastie Boys. Thanks to his close association with the Rock and Roll Hall of Fame inductees, he was endearingly known throughout the music industry as the honorary fourth Beastie Boy, especially after garnering a hilarious shout-out on their song “Car Thief.” While known as an iconic photographer, Powell was also the author of several photo books, including The Individualist, Public Access, The Rickford Files, and more. The Brooklyn-born photographer also helmed the popular 90s show Rappin’ With the Rickster, in which he interviewed prominent artists of the time, including Doug E Fresh, Cypress Hill,   Read more…

AIkido Pharma Adds Inventor Dr. Neil H. Bander, M.D. to Scientific Advisory Board

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Dr. Neil H. Bander, M.D., a physician-researcher at Weill Cornell Medicine, has joined the Company’s Scientific Advisory Board. (PRNewsfoto/AIkido Pharma Incorporated) “Dr. Bander heads one of the world’s most experienced and accomplished teams in antibody-targeted therapy of prostate cancer at Cornell University and is a widely respected inventor of patented technologies and recognized expert in the field of urological oncology,” commented Mr. Anthony Hayes, CEO of AIkido. “Importantly, Dr. Bander is the inventor of targeted radiopharmaceutical therapy technology at Convergent Therapeutics, Inc. which we are proud to support. We are honored to have him join our team of advisors and work more directly in our efforts to advance the development of this technology.”   “Using his clinical background and laboratory efforts, Dr. Bander has exemplified the role of surgeon-scientist,” added Mr. Hayes. “His research has spawned novel clinical trials that are unique in urological oncology and have already made a difference in the lives of prostate cancer patients. We look forward to leveraging his expertise as we continue to develop our platforms and forge a path towards the treatment of cancer.” Dr. Bander, M.D. completed fellowship training in both tumor immunology   Read more…

Findit Features Members Twist 25, Regan Patterson, Elle Valentine and Urban CBD Collective

Findit, Inc. (OTC PINK:FDIT) owner of Findit.com, a full-service social networking platform that provides online marketing campaigns and tools for members to increase brand awareness through content creation and sharing, resulting in indexing in search engines is highlighting: Twist 25, Regan Patterson, Elle Valentine, and Urban CBD Collective. Our first featured Findit member is Twist 25. Twist 25 DHEA Cream is a healthy, all-natural, bioidentical DHEA supplement that is intended to be used twice daily by men and women over the age of 25 who are looking to maintain DHEA levels past age 35. As you age, you produce less DHEA naturally, so it is important to maintain DHEA levels with Twist 25. Using Twist 25 daily can provide us with numerous health benefits such as better sleep, more energy, improved sex drive, ability to help reduce belly fat, softer skin, and more. Whether buying Twist 25 for your friends, family, or for yourself, Twist 25 helps you stay healthy and feel great + boost your immune system. Twist 25 DHEA cream is the perfect gift to help you feel and look your best + boost the immune system, reduce risks of heart disease and cancer, help you sleep better at night,   Read more…

Aikido Pharma Secures Early Interest in Next Generation Radiotherapy

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that the Company executed a Two Million Dollar Convertible Promissory Note Purchase Agreement with Convergent Therapeutics, Inc., securing an early investment in Convergent. Convergent has exclusive rights to technology related to next generation radiopharmaceutical therapy for prostate cancer that is covered by multiple issued U.S. and foreign patents. Convergent is currently conducting advanced human trials relating to prostate cancer treatments involving peptide receptor radionuclide therapy (“PRRT”) that targets the prostate-specific membrane antigen (“PSMA”) present on prostate cancer cells. The technology was developed under the direction of Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine.   The key component of Convergent’s PRRT prostate cancer therapy is its proprietary drug, CONV 01-α, a monoclonal antibody conjugated with 225Ac, a radioactive alpha particle emitter. The function of CONV 01-α is unique in that it not only binds specifically to the PSMA receptor on prostate cancer cells, but also stimulates the internalization of the receptor along with itself and its powerful radioactive payload directly into tumor cells. Convergent is presently conducting two sets of human clinical trials using CONV 01-α as a single agent treatment for prostate cancer. The first is a Phase 1a/2a   Read more…

OTC Tip Reporter Announces Market News From Aikido Pharma Who Secured Early Interest in Next Generation Radiotherapy with Convergent Therapeutics, Inc.

Companies that trade on the NASDAQ or NYSE that are looking to remain qualified and increase visibility and exposure on the markets rely on OTC Tip Reporter. If your company is on the verge of being delisted from NASDAQ or the New York Stock Exchange (NYSE), OTC Tip Reporter can help you remain qualified. OTC Tip Reporter has been helping companies for years get their story out to investors and current shareholders that can assist these companies in remaining qualified on both NASDAQ and or the New York Stock Exchange (NYSE).   Today, AIkido Pharma Inc. (Nasdaq: AIKI) announced that the Company executed a Two Million Dollar Convertible Promissory Note Purchase Agreement with Convergent Therapeutics, Inc., securing an early investment in Convergent. Convergent has exclusive rights to technology related to next generation radiopharmaceutical therapy for prostate cancer that is covered by multiple issued U.S. and foreign patents. Convergent is currently conducting advanced human trials relating to prostate cancer treatments involving peptide receptor radionuclide therapy (“PRRT”) that targets the prostate-specific membrane antigen (“PSMA”) present on prostate cancer cells. The technology was developed under the direction of Dr. Neil Bander, Professor of Urologic Oncology at Weill Cornell Medicine. OTC Tip Reporter offers investor relations   Read more…

Page 3 of 41234